David Slawson, MD recently did the first “across the pond” podcast with three pharmacists from the UK as part of the second series of their highly successful “The Aural Apothecary” . All three fondly reminisced at having attended a live Information Mastery workshop in the past that they strongly felt “transformed” their entire world view. They even pulled out and proudly displayed their original CD and class handouts from the course! Dr. Slawson discussed some micro thoughts on the recent paper he and Dr. Shaughnessy published in BMJ EBM entitled “Reducing Overuse By Recognizing the Unintended Harm of Good Intentions“.… Read more »
Information Mastery teaching causes strong emotional responses and transforms entire thinking and decision-making process. See: “Making the Most of Continuing Medical Education: Evidence of Transformative Learning During a Course in Evidence-Based Medicine and Decision Making”
Giving a blood sample, sliding into a scanner, even lying on the stainless steel bed of an x-ray machine — A diagnostic test, while not anyone’s idea of fun, is not that big a deal, right? Those of us in the medical biz are well aware of the risk of harm associated with surgery or other procedures and the expected and unexpected adverse effects of medicines. We tend to forget, though, that diagnostic tests can also cause harm. It’s not the test itself, that is risky, it’s the results — and what we do with them — that can do… Read more »
I used to have the “bedside stack.” This pile of journals that I planned to read was always topped by. . . the latest Stephen King novel.
Now my e-mail in-box is filled with “online first” and “table of contents” announcements from numerous journals.
The problem with reading journal articles is obvious: they are hard to read. They seem to be written in English, but not in a language I use day to day.…Read More »
The outrage is building. Drug prices are nothing less than astounding. The American Academy of Family Physicians is just the latest group to join The Campaign for Sustainable Rx Pricing, a non-partisan coalition aiming lower drug prices in the U.S. From AARP to professional societies to insurance companies to Wal-Mart, the coalition is attempting, through legislative support, to slow the rapid growth of drug costs.…Read More »
Last week the Food and Drug Administration approved the marketing of a 23-and-me, a test previously marketed as a way to trace ancestry, for screening individual’s genetic predisposition to certain medical diseases or conditions.
At first glance it might make sense. Screening to know one’s genetic profile for a disease should be helpful, right?
Not so.…Read More »
The Bill & Melinda Gates Foundation spends $4billion a year supporting scientific endeavors, much of it on medical research. But you won’t be reading about any of their breakthroughs in JAMA, New England Journal of Medicine, or The Lancet. No, as of last week the Foundation is doing an end-run around medical journals, requiring that all research findings be freely available in an online repository.
This move reflects the Foundation’s – and many others’ – frustration with medical research journal publishers’ controlling of access to studies and the resulting slow dissemination of research findings.…Read More »
In part 1 of this post, I talked about how medical research journals rose to become the standard-bearers for disseminating new research findings. In this post I will focus on how medical research journals slow down – way down – the spread of research, and speculate on the growing role of social media.
“I’ll do a Medline search.”
“I found an article.”
“My research was published in [insert medical research journal].”
“According to the [insert medical research journal]. . .”